Tenosynovial giant cell tumor (TGCT) is a group of rare, typically non-malignant tumors of the joints. TGCT tumors often develop from the lining of joints...

of the HMGA2 gene. Tenosynovial giant cell tumor (not a sarcoma, but a non-metastasizing and locally aggressive soft tissue tumor) frequently is associated...

inhibitor drug for the treatment of adults with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations...

cabiralizumab (cabira; FPA-008), an anti-CSF1R antibody, in tenosynovial giant cell tumor (TGCT, diffuse pigmented villonodular synovitis D-PVNS)". Journal...

Synovial osteochondromatosis Plica syndrome villonodular synovitis Tenosynovial giant cell tumor Bursopathy Bursitis Olecranon Prepatellar Trochanteric Subacromial...

Synovial osteochondromatosis Plica syndrome villonodular synovitis Tenosynovial giant cell tumor Bursopathy Bursitis Olecranon Prepatellar Trochanteric Subacromial...

cell tumor Fibrous histiocytoma of tendon sheath Giant cell tumor of tendon sheath M9252/3 Malignant tenosynovial giant cell tumor Giant cell tumor of...

with a manageable safety profile in patients with diffuse-type tenosynovial giant cell tumors (d-TGCT). Emactuzumab was originally developed by Roche/Genentech...

in patients with tenosynovial giant cell tumor was started (NCT05804045). Following with pimicotinib for tenosynovial giant cell tumor treatment in phase...

CSF1R-positive tenosynovial giant cell tumor cell lines and their pexidartinib (PLX3397) and sotuletinib (BLZ945)-induced apoptosis". Human Cell. 36 (1): 456–467...

was FDA-approved for treatment of diffuse-type tenosynovial giant cell tumors, a non-malignant tumor that develops from synovial tissue lining the joints...

Genentech diffuse large B-cell lymphoma Pexidartinib Daiichi Sankyo tenosynovial giant cell tumor Entrectinib Genentech solid tumors that have a neurotrophic...

2009). "Clusterin is expressed in normal synoviocytes and in tenosynovial giant cell tumors of localized and diffuse types: diagnostic and histogenetic...

"CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: A dose-escalation and dose-expansion...